Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hwa Sheng

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Psychiatry Research|May 7, 2011
White matter abnormalities of fronto-striato-thalamic circuitry in obsessive-compulsive disorder: A study using diffusion spectrum imaging tractographyChen-Huan Chiu, Yu-Chun Lo, Hwa-Sheng Tang, et al.
Pharmacogenomics|March 31, 2010
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment responseMing-Hsien Tsai, Keh-Ming Lin, Mei-Chun Hsiao, et al.
International Clinical Psychopharmacology|July 25, 2013
Comparison of escitalopram and paroxetine in the treatment of major depressive disorderHuang-Li Lin, Ya-Ting Hsu, Chia-Yih Liu, et al.
Pharmacogenomics|December 3, 2010
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetineKeh-Ming Lin, Hsiao-Hui Tsou, I-Ju Tsai, et al.
Pharmacogenetics and Genomics|September 23, 2010
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatmentKeh-Ming Lin, Yen-Feng Chiu, I-Ju Tsai, et al.
Pharmacogenomics|July 18, 2013
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactionsHsiang-Wei Kuo, Shu Chih Liu, Hsiao-Hui Tsou, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Psychiatry Research|May 7, 2011
White matter abnormalities of fronto-striato-thalamic circuitry in obsessive-compulsive disorder: A study using diffusion spectrum imaging tractographyChen-Huan Chiu, Yu-Chun Lo, Hwa-Sheng Tang, et al.
Pharmacogenomics|March 31, 2010
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment responseMing-Hsien Tsai, Keh-Ming Lin, Mei-Chun Hsiao, et al.
International Clinical Psychopharmacology|July 25, 2013
Comparison of escitalopram and paroxetine in the treatment of major depressive disorderHuang-Li Lin, Ya-Ting Hsu, Chia-Yih Liu, et al.
Pharmacogenomics|December 3, 2010
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetineKeh-Ming Lin, Hsiao-Hui Tsou, I-Ju Tsai, et al.
Pharmacogenetics and Genomics|September 23, 2010
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatmentKeh-Ming Lin, Yen-Feng Chiu, I-Ju Tsai, et al.
Pharmacogenomics|July 18, 2013
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactionsHsiang-Wei Kuo, Shu Chih Liu, Hsiao-Hui Tsou, et al.
Pageof 2